The 12 closest competitors and alternatives to Thylacine Biotherapeutics Inc — ranked by similarity to what Thylacine Biotherapeutics Inc actually does, not by market-cap band.
Subscribe to see Thylacine Biotherapeutics Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Thylacine Biotherapeutics Inc. is a privately held biotech company headquartered in Miami Beach, Florida, dedicated to combating infectious diseases. The company develops a drug pipeline addressing both commercial and biothreat indications, including novel antiviral peptides.
Thylacine Biotherapeutics Inc is a company headquartered in United States. Its most recent funding round raised $476,000 in January 2023. Xcout tracks 10 named people at Thylacine Biotherapeutics Inc, including Daniel Graifman (President).
4 more named people on record for Thylacine Biotherapeutics Inc, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $476,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Thylacine Biotherapeutics Inc by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
Pharmaceuticals, Biotechnology & Life Sciences
Island Pharmaceuticals Ltd is an Australian antiviral drug development company based in Melbourne, Australia, focused on addressing infectious diseases.
Close match by what they do
Immorta Bio, Inc. is a regenerative medicine and scientific longevity company dedicated to providing innovative health solutions. Headquartered in Miami Beach, Florida, the company develops specialized therapeutics and operates within the biotechnology sector.
Close match by what they do
Canlab International is a supplier of high-purity research peptides based in Miami Beach, Florida. The company provides specialized research products while noting that its statements have not been evaluated by the U.S. Food and Drug Administration.
Close match by what they do
Vaxxinity, Inc. is a biotechnology company committed to democratizing healthcare globally through proprietary synthetic peptide immunotherapies, maintaining operations and a headquarters facility in Florida.
Biotechnology
Maxwell Biosciences, Inc. is a biotechnology company based in Austin, Texas. It develops biomimetic, peptide-inspired anti-infective drugs designed to act as a synthetic immune system.
Close match by what they do
Tamir Biotechnology, Inc. is a private biotechnology company founded in 1981 and headquartered in Somerset, New Jersey. The company focuses on drug pipelines, patents, clinical development, and features a broad-spectrum antiviral platform.
Biotechnology
TigaTx is a Boston-based biotechnology company founded in 2018 that is developing a pipeline of therapies targeting various cancer types and infectious diseases.
Close match by what they do
Klothea Bio, Inc. is a biotechnology research company based in Miami, Florida, focused on advancing research and development of the Klotho protein for age-related therapeutics.
Close match by what they do
Tetherex Pharmaceuticals Corp is a biotechnology company focused on drug development and therapeutic pipelines, including indications related to COVID-19.
Biopharmaceuticals
Cidara Therapeutics, Inc. is a biotechnology company focused on developing late-phase antiviral and immunotherapy agents, with operations based in San Diego, California and Rahway, New Jersey.
Biotech
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Thylacine Biotherapeutics Incand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →